Literature DB >> 15869613

Increased plasminogen activator inhibitor-1 levels in android obesity: correlation with oxidative stress.

P Ferroni, M T Guagnano, M R Manigrasso, G Ciabattoni, G Daví.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15869613     DOI： 10.1111/j.1538-7836.2005.01395.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial.

Authors:  P Bogdanski; M Szulinska; J Suliburska; D Pupek-Musialik; A Jablecka; H Witmanowski
Journal:  J Endocrinol Invest       Date:  2012-06-25       Impact factor: 4.256

Review 2.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

Review 3.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

4.  Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.

Authors:  Praveen K Vayalil; Karen E Iles; Jinah Choi; Ae-Kyung Yi; Edward M Postlethwait; Rui-Ming Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-09-21       Impact factor: 5.464

Review 5.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.